On Friday, Shares of Amgen, Inc. (NASDAQ:AMGN), subtract -1.67% and closed at $149.04 in the last trading session. The last trading range of the stock ranges between $146.80 and $150.84. The company’s Market capitalization is $109.02 Billion with the total Outstanding Shares of 743.92 million. Amgen (AMGN) and UCB (Euronext Brussels: UCB) recently declared results from the Phase 3 BRIDGE study showing that in men with osteoporosis, the investigational agent romosozumab resulted in noteworthybone mineral density (BMD) gains at the lumbar spine, total hip and femoral neck contrast to placebo at six and 12 months. The full findings will be presented for the first time at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Meeting in Washington, D.C., Nov. 11-16, 2016 (abstract #321).
Although more common in women, osteoporosis is also a serious health issue for men. One in five men over the age of 50 worldwide will have an osteoporosis-related fracture – an incidence that is greater than the development of prostate cancer.1 Men are less likely to be diagnosed with osteoporosis and treated, while fractures can be associated with raised rates of disability contrast to women.1
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $133.64 and reached to max level of $176.85. The EPS of company is strolling at 10.01.
Shares of United Continental Holdings Inc (NYSE:UAL), jumped 0.52% and closed at $60.25 in the last trading session. The last trading range of the stock ranges between $58.78 and $60.58. The company’s Market capitalization is $19.22 Billion with the total Outstanding Shares of 317.29 million. United Airlines (UAL) recently stated October 2016 operational results.
UAL’s October 2016 merged traffic (revenue passenger miles) raised 0.6 percent and merged capacity (available seat miles) raised 1.8 percent as compared to October 2015. UAL’s October 2016 merged load factor reduced 1.0 point contrast to October 2015.
The company continues to expect fourth-quarter 2016 merged passenger unit revenue to decline 4.0 to 6.0 percent contrast to the fourth quarter of 2015. The year-over-year performance is driven mainly by yield weakness and the timing of certain holidays.
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $37.41 and reached to max level of $61.60. The EPS of company is strolling at 8.14.